Michael E. Stern
21Patents
5h-index
21Co-inventors
69Inventor score
Filing activity: Oct 18, 1984 → Oct 11, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5863892A | Use of platelet derived growth factor in ophthalmic wound healing | Human Necessities | 55 | Expired |
| US6294553A | Method for treating ocular pain | Human Necessities | 36 | Expired |
| US4939135A | Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation | Human Necessities | 28 | Expired |
| US4657727A | Fission product barrier emergency event classification and response system | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5221537A | Tissue irrigating solutions | Human Necessities | 6 | Expired |
| US9175042B2 | Cyclosporin analogs | Chemistry; Metallurgy | 4 | Active |
| US8524671B2 | Cyclosporin derivatives for treating inflammatory diseases and conditions | Human Necessities | 2 | Active |
| US9493511B2 | Cyclosporin analogs | Human Necessities | 2 | Active |
| US8211434B2 | KLK-13 antibody inhibitor for treating dry eye | Human Necessities | 2 | Active |
| US7135455B2 | Methods for the therapeutic use of cyclosporine components | Human Necessities | 1 | Expired |
| US8491905B2 | KLK-13 antibody inhibitor for treating dry eye | Human Necessities | 1 | Active |
| US7368426B2 | Methods for the therapeutic use of cyclosporine components | Human Necessities | 1 | Expired |
| US7151085B2 | Therapeutic methods using cyclosporine components | Human Necessities | 1 | Expired |
| US10065992B2 | Cyclosporin analogs | Human Necessities | 1 | Active |
| US7902155B2 | Therapeutic methods using cyclosporine components | Human Necessities | 0 | Active |
| US9457060B2 | Therapeutic methods using cyclosporine components | Human Necessities | 0 | Active |
| US8491912B2 | Methods of treating ocular and other diseases with Syn-134R polypeptide | Chemistry; Metallurgy | 0 | Active |
| US10869955B2 | Joint fat pad formulations, and methods of use thereof | Human Necessities | 0 | Active |
| US8821874B2 | KLK-13 antibody inhibitor for treating dry eye | Human Necessities | 0 | Active |
| US9561259B2 | Cyclosporin analogs | Chemistry; Metallurgy | 0 | Active |
| US10736936B2 | Therapeutic methods using cyclosporine components | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.